Actively Recruiting
Profile-Related Evidence Determining Individualized Cancer Therapy in Pancreatic Cancer (PREDICT-PANC)
Led by Medical College of Wisconsin · Updated on 2026-05-05
1000
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to explore precision oncology for adults with pancreatic cancer by collecting and analyzing data to understand how personalized treatments based on molecular tumor profiling work. The study evaluates how well molecular testing predicts patient responses to targeted therapies and assesses outcomes like tumor response, time to treatment failure, survival, and treatment tolerability. The study is observational and non-therapeutic, examining patient medical records both retrospectively and prospectively. It focuses on examining results from molecular profiling obtained through standard care to guide targeted therapy decisions. Approved targeted therapies based on each patient's genomic profile are considered by investigators for potential anti-tumor treatment. Participants will have their demographic and clinical data reviewed, including tumor response and survival outcomes. Researchers will monitor how many subjects receive targeted therapy over five years. The study involves no direct intervention or treatment administration by the research team. Participation includes data collection from medical records and ongoing tracking of treatment outcomes to better understand personalized therapy in pancreatic cancer.
CONDITIONS
Brief Title
Determining Individualized Cancer Therapy in Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 218 years.
- Pathologically confirmed pancreatic cancer.
- Ability to understand and willingness to sign a written informed consent document.
You will not qualify if you...
- Age <18 years.
- Primary cancer diagnosis other than pancreatic cancer.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Initial assessment period
Participants undergo genomic profiling to determine individualized cancer therapy options based on their pancreatic cancer.
Duration - Up to 5 years
Participants are observed over time to assess the use and outcomes of targeted therapies guided by their genomic profile.
Trial Site Locations
Total: 1 location
1
Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226
Actively Recruiting
Research Team
C
Cancer Center Clinical Trials Office
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here